Kif15 inhibitor 1 free base

Kif15-IN-1 is an inhibitor of the mitotic Kinesin family member 15 (Kif15), and is used for the research of cellular proliferative diseases.

For research use only. Not for human or veterinary use.

Target Kinesin

Research area Cardiovascular Disease Inflammation/Immunology Cancer

Purity >98% Stock Inquire

Data Sheet SDS COA

Kif15 inhibitor 1 structure

CAS No.: 672926-32-8

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
100 mg	USD 450.00	BP-02386-100mg	In stock	Get quote
250 mg	USD 766.00	BP-02386-250mg	In stock	Get quote
500 mg	USD 1,288.00	BP-02386-500mg	In stock	Get quote
1 g	USD 1,988.00	BP-02386-1g	In stock	Get quote
2 g	Inquire	BP-02386-2g	In stock	Inquire

Need another size or custom synthesis? Request a quote.

Description

Kif15-IN-1 is an inhibitor of the mitotic Kinesin family member 15 (Kif15), and is used for the research of cellular proliferative diseases.

Biological activity

In Vitro Kif15-IN-1 (Compound 10) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against cellular proliferative diseases such as cancer, hyperplasias, cardiac hypertrophy, immune disorders and inflammation

Identifiers

SMILES: CCOC(=O)C1=C(N=C(S1)NC(=O)[C@H](C(C)C)N2C(=O)C3=CC=CC=C3NC2=O)C
InChIKey: CTQQKICGMSZCJL-AWEZNQCLSA-N

Specifications

MW (average): 430.4770
Formula: C₂₀H₂₂N₄O₅S
CAS No.: 672926-32-8
Physical state: Solid
Color: White to off-white
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder -20°C, 3 years , 4°C, 2 years; In solvent -20°C, 1 month;

Solubility

Soluble in DMSO

In vitro: DMSO : ≥ 100 mg/mL

Documents

References

[1]. Preparation of quinazolinediones as Kif15 kinesin inhibitors for treating cellular proliferative disorders. Pat. Appl. Publ. (2004), US 20040053948 A1 20040318.

Same target

Search Kinesin

Same research area

Search Cardiovascular Disease